General Announcement::Outcome of the Board Meeting - November 14. 2019

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
14-Nov-2019 21:29:00
Status
New
Announcement Sub Title
Outcome of the Board Meeting - November 14. 2019
Announcement Reference
SG191114OTHRU7TE
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Ltd.
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
14/11/2019 00:00:00
Description (Please provide a detailed description of the event in the box below)
Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, we wish to inform you that Board has today at its meeting approved the Unaudited Financial Results for the Second Quarter and Half Year ended September 30, 2019.

The said meeting of the Board commenced at 2.00 p.m. and concluded at 6.05 p.m.

The copy of the said results together with Management Discussion & Analysis, Press Release and Limited Review Report of the Auditors is enclosed herewith.

These are also being made available on the website of the Company at www.glenmarkpharma.com.

Attachments

BSE_NSE_RESULT_14112019.pdf
Total size =9620K